At Risk Persons

Lo que usted debe saber sobre su medicamento para la infección latente de tuberculosis (TB) – Rifampin

The Latent TB Infection (LTBI) Treatment Fact Sheet Series is designed to complement patient education delivered by healthcare professionals. Each sheet provides patients with a written reminder of their treatment regimen, medication side effects, actions to take if side effects do occur, tips to help remain adherent to the medication, and instructions in the event a dose of medication is missed.

Back to Results

Simple Ways to Make the Health of Gay Men a Priority

Infographic on STD screening of MSM, specifically of the throat and rectum.

Back to Results

The Case For New Multipurpose Prevention Technologies

Lauren Hunter, a doctoral student at UC Berkeley, presented the "Contraceptive method use and chlamydia positivity among California family planning clients: the case for new Multipurpose Prevention Technologies," an analysis comparing chlamydia positivity by type of contraceptive method used among women tested through California's Family PACT program in 2012-2013. In the presentation, she discusses the implications of the findings and how the development and provision of additional Multipurpose Prevention Technologies (MPTs) may help to address an unmet need for STI prevention.

Back to Results

TB Personal Stories - Kate

This story highlights the personal experiences of a Tuberculosis (TB) survivor who was diagnosed and treated for TB disease. The survivor details the challenges of a lengthy hospital stay, her worries over how TB medicines would affect her pregnancy and baby, and her work as an advocate since recovering from TB.

Back to Results

HBV ECHO: Reducing Perinatal Transmission

Video developed through partnership with the Department of Health and Human Resources (HHS) Health Resources and Services Administration's (HRSA) Bureau of Primary Health Care, Project ECHO launched HBV ECHO, a national technical assistance program that helps enhance HRSA-funded health center capacity to reduce perinatal transmission of hepatitis B. Panelists discuss the teleECHO™ curriculum, challenges in addressing perinatal HBV in the primary care setting, and patient case studies.

Back to Results